Cases 41 - 50 of 3,514
SILVERIO v. Boehringer Ingelheim Corp. et al
as 3:2023cv23062
Plaintiff:
ROBERT SILVERIO
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Linda Cassidy et al., v. Boehringer Ingelheim Corp. et al
as 3:2023cv23061
Plaintiff:
Linda Cassidy
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bayer Pharma AG et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2023cv00410
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc., Dr. Reddy's Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Jackson et al v. GlaxoSmithKline LLC et al
as 3:2023cv15362
Plaintiff:
Deborah Jackson and Jason Jackson
Defendant:
GlaxoSmithKline LLC, GlaxoSmithKline (America) Inc., GlaxoSmithKline plc and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Ayscue v. GlaxoSmithKline (America) Inc.
as 3:2023cv20455
Plaintiff:
Clarence Ayscue
Defendant:
GlaxoSmithKline (America) Inc., GlaxoSmithKline LLC, GlaxoSmithKline PLC (UK) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity
Modzel v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 3:2023cv22523
Plaintiff:
Dennis Modzel, Sr.
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity
Poullas v. Boehringer Ingelheim Pharmaceuticals, Inc.
as 3:2023cv22611
Plaintiff:
George Poullas
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity
Anderson v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 3:2023cv22888
Plaintiff:
Dawn Anderson and The Estate of Angelo Abbate
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity
Burgess et al v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 3:2023cv22207
Plaintiff:
Howell Burgess and Melanie Burgess
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, GlaxoSmithKline (API Mfr to BI) and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
